Table 2.
Drugs (5 μg/ml) | CFU per mL after drug exposure |
---|---|
Drug free control | 2.8 ± 0.4 × 1010 |
Amikacin | 8.0 ± 0.2 × 104 |
Azithromycin | 6.5 ± 0.4 × 105 |
Cefuroxime | 2.2 ± 0.2 × 105 |
Ciprofloxacin | 6.0 ± 0.1 × 102 |
Clofazimine | 1.6 ± 0.2 × 1010 |
Daptomycin | 5.0 ± 0.2 × 107 |
Disulfiram | 1.0 ± 0.2 × 107 |
Doxycycline | 8.0 ± 0.3 × 106 |
Gentamicin | 5.0 ± 0.2 × 102 |
Methylene blue | 3.2 ± 0.4 × 104 |
Miconazole | 1.5 ± 0.1 × 1010 |
Nitrofurantoin | 2.8 ± 0.1 × 102 |
Rifampin | 6.0 ± 0.3 × 105 |
SXT | 3.5 ± 0.2 × 106 |
Azithromycin+Amikacin | 4.3 ± 0.3 × 105 |
Azithromycin+Rifampin | 2.0 ± 0.2 × 105 |
Azithromycin+Cefuroxime | 5.2 ± 0.2 × 105 |
Azithromycin+Ciprofloxacin | 0 |
Azithromycin+Clofazimine | 2.2 ± 0.3 × 106 |
Azithromycin+Daptomycin | 1.8 ± 0.1 × 105 |
Azithromycin+Disulfiram | 1.4 ± 0.2 × 105 |
Azithromycin+Doxycycline | 1.2 ± 0.3 × 106 |
Azithromycin+Gentamicin | 5.1 ± 0.3 × 104 |
Azithromycin+Methylene blue | 0 |
Azithromycin+Miconazole | 1.3 ± 0.2 × 105 |
Azithromycin+Nitrofurantoin | 4.0 ± 0.3 × 105 |
Azithromycin+SXT | 8.5 ± 0.1 × 106 |
Rifampin+ Amikacin | 1.6 ± 0.1 × 105 |
Rifampin+Cefuroxime | 2.2 ± 0.1 × 104 |
Rifampin+Ciprofloxacin | 0 |
Rifampin+Clofazimine | 2.8 ± 0.1 × 105 |
Rifampin+Daptomycin | 1.2 ± 0.1 × 106 |
Rifampin+Disulfiram | 8.5 ± 0.2 × 105 |
Rifampin+Doxycycline | 1.2 ± 0.1 × 106 |
Rifampin+Gentamicin | 1.6 ± 0.1 × 104 |
Rifampin+Methylene blue | 0 |
Rifampin+ Miconazole | 8.0 ± 0.3 × 105 |
Rifampin+Nitrofurantoin | 1.2 ± 0.1 × 105 |
Rifampin+SXT | 1.6 ± 0.1 × 105 |
aStationary phase B. henselae (6-day old) cells were treated with 5 μg/ml drugs alone or drug combinations for 24 h when the survival of the bacteria was determined by CFU count after wash (see Methods for more details)